GURUFOCUS.COM » STOCK LIST » Industrials » Transportation » Kinarus Therapeutics Holding AG (XSWX:KNRS) » Definitions » Asset Turnover

Kinarus Therapeutics Holding AG (XSWX:KNRS) Asset Turnover : 0.00 (As of Dec. 2021)


View and export this data going back to 1999. Start your Free Trial

What is Kinarus Therapeutics Holding AG Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Kinarus Therapeutics Holding AG's Revenue for the six months ended in Dec. 2021 was CHF0.00 Mil. Kinarus Therapeutics Holding AG's Total Assets for the quarter that ended in Dec. 2021 was CHF0.16 Mil. Therefore, Kinarus Therapeutics Holding AG's Asset Turnover for the quarter that ended in Dec. 2021 was 0.00.

Asset Turnover is linked to ROE % through Du Pont Formula. Kinarus Therapeutics Holding AG's annualized ROE % for the quarter that ended in Dec. 2021 was 112.82%. It is also linked to ROA % through Du Pont Formula. Kinarus Therapeutics Holding AG's annualized ROA % for the quarter that ended in Dec. 2021 was -222.08%.


Kinarus Therapeutics Holding AG Asset Turnover Historical Data

The historical data trend for Kinarus Therapeutics Holding AG's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kinarus Therapeutics Holding AG Asset Turnover Chart

Kinarus Therapeutics Holding AG Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Asset Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.65 6.07 7.93 3.57 -

Kinarus Therapeutics Holding AG Semi-Annual Data
Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.19 3.55 -0.77 - -

Competitive Comparison of Kinarus Therapeutics Holding AG's Asset Turnover

For the Airports & Air Services subindustry, Kinarus Therapeutics Holding AG's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kinarus Therapeutics Holding AG's Asset Turnover Distribution in the Transportation Industry

For the Transportation industry and Industrials sector, Kinarus Therapeutics Holding AG's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Kinarus Therapeutics Holding AG's Asset Turnover falls into.



Kinarus Therapeutics Holding AG Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Kinarus Therapeutics Holding AG's Asset Turnover for the fiscal year that ended in Dec. 2021 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Dec. 2021 )/( (Total Assets (A: Dec. 2020 )+Total Assets (A: Dec. 2021 ))/ count )
=0/( (0.127+0.136)/ 2 )
=0/0.1315
=0.00

Kinarus Therapeutics Holding AG's Asset Turnover for the quarter that ended in Dec. 2021 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Dec. 2021 )/( (Total Assets (Q: Jun. 2021 )+Total Assets (Q: Dec. 2021 ))/ count )
=0/( (0.181+0.136)/ 2 )
=0/0.1585
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


Kinarus Therapeutics Holding AG  (XSWX:KNRS) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Kinarus Therapeutics Holding AG's annulized ROE % for the quarter that ended in Dec. 2021 is

ROE %**(Q: Dec. 2021 )
=Net Income/Total Stockholders Equity
=-0.352/-0.312
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-0.352 / 0)*(0 / 0.1585)*(0.1585/ -0.312)
=Net Margin %*Asset Turnover*Equity Multiplier
= %*0*-0.508
=ROA %*Equity Multiplier
=-222.08 %*-0.508
=112.82 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2021) net income data. The Revenue data used here is two times the semi-annual (Dec. 2021) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Kinarus Therapeutics Holding AG's annulized ROA % for the quarter that ended in Dec. 2021 is

ROA %(Q: Dec. 2021 )
=Net Income/Total Assets
=-0.352/0.1585
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-0.352 / 0)*(0 / 0.1585)
=Net Margin %*Asset Turnover
= %*0
=-222.08 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2021) net income data. The Revenue data used here is two times the semi-annual (Dec. 2021) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Kinarus Therapeutics Holding AG Asset Turnover Related Terms

Thank you for viewing the detailed overview of Kinarus Therapeutics Holding AG's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Kinarus Therapeutics Holding AG (XSWX:KNRS) Business Description

Traded in Other Exchanges
N/A
Address
3, Avenue de Florimont, Lausanne, CHE, CH-1006
Perfect Holding SA is a Switzerland-based company that focuses on the acquisition and management of investments in companies, which are active in the aircraft management and related services sector. The company operates in one business segment which includes Charters. The products provided by the company include Aircraft sales, Charter sales, and Aircraft consultancy.

Kinarus Therapeutics Holding AG (XSWX:KNRS) Headlines

No Headlines